These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 19631735

  • 1. Developmental and peri-postnatal study in cynomolgus monkeys with belimumab, a monoclonal antibody directed against B-lymphocyte stimulator.
    Auyeung-Kim DJ, Devalaraja MN, Migone TS, Cai W, Chellman GJ.
    Reprod Toxicol; 2009 Dec; 28(4):443-55. PubMed ID: 19631735
    [Abstract] [Full Text] [Related]

  • 2. Chronic administration of belimumab, a BLyS antagonist, decreases tissue and peripheral blood B-lymphocyte populations in cynomolgus monkeys: pharmacokinetic, pharmacodynamic, and toxicologic effects.
    Halpern WG, Lappin P, Zanardi T, Cai W, Corcoran M, Zhong J, Baker KP.
    Toxicol Sci; 2006 Jun; 91(2):586-99. PubMed ID: 16517838
    [Abstract] [Full Text] [Related]

  • 3. An Enhanced Pre- and Postnatal Development Study in Cynomolgus Monkeys with Tabalumab: A Human IgG4 Monoclonal Antibody.
    Breslin WJ, Hilbish KG, Martin JA, Halstead CA, Newcomb DL, Chellman GJ.
    Birth Defects Res B Dev Reprod Toxicol; 2015 Jun; 104(3):100-16. PubMed ID: 26195230
    [Abstract] [Full Text] [Related]

  • 4. Developmental immunotoxicology assessment of rituximab in cynomolgus monkeys.
    Vaidyanathan A, McKeever K, Anand B, Eppler S, Weinbauer GF, Beyer JC.
    Toxicol Sci; 2011 Jan; 119(1):116-25. PubMed ID: 20937725
    [Abstract] [Full Text] [Related]

  • 5. Postnatal development in cynomolgus monkeys following prenatal exposure to natalizumab, an alpha4 integrin inhibitor.
    Wehner NG, Shopp G, Osterburg I, Fuchs A, Buse E, Clarke J.
    Birth Defects Res B Dev Reprod Toxicol; 2009 Apr; 86(2):144-56. PubMed ID: 19283860
    [Abstract] [Full Text] [Related]

  • 6. Embryo/fetal development in cynomolgus monkeys exposed to natalizumab, an alpha4 integrin inhibitor.
    Wehner NG, Shopp G, Oneda S, Clarke J.
    Birth Defects Res B Dev Reprod Toxicol; 2009 Apr; 86(2):117-30. PubMed ID: 19278014
    [Abstract] [Full Text] [Related]

  • 7. Development in the cynomolgus macaque following administration of ustekinumab, a human anti-IL-12/23p40 monoclonal antibody, during pregnancy and lactation.
    Martin PL, Sachs C, Imai N, Tsusaki H, Oneda S, Jiao Q, Treacy G.
    Birth Defects Res B Dev Reprod Toxicol; 2010 Oct; 89(5):351-63. PubMed ID: 20540088
    [Abstract] [Full Text] [Related]

  • 8. Pre- and postnatal development in the cynomolgus monkey following administration of ABT-874, a human anti-IL-12/23p40 monoclonal antibody.
    Enright BP, Tornesi B, Weinbauer GF, Blaich G.
    Birth Defects Res B Dev Reprod Toxicol; 2012 Dec; 95(6):431-43. PubMed ID: 23212752
    [Abstract] [Full Text] [Related]

  • 9. Embryo-fetal developmental toxicity of figitumumab, an anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody, in cynomolgus monkeys.
    Bowman CJ, Chmielewski G, Oneda S, Finco D, Boucher MA, Todd M.
    Birth Defects Res B Dev Reprod Toxicol; 2010 Aug; 89(4):326-38. PubMed ID: 20540090
    [Abstract] [Full Text] [Related]

  • 10. Generation and characterization of human B lymphocyte stimulator blocking monoclonal antibody.
    Zhuang W, Zhang J, Pei L, Fang S, Liu H, Wang R, Su Y.
    Mol Immunol; 2016 Sep; 77():141-7. PubMed ID: 27505709
    [Abstract] [Full Text] [Related]

  • 11. Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator.
    Baker KP, Edwards BM, Main SH, Choi GH, Wager RE, Halpern WG, Lappin PB, Riccobene T, Abramian D, Sekut L, Sturm B, Poortman C, Minter RR, Dobson CL, Williams E, Carmen S, Smith R, Roschke V, Hilbert DM, Vaughan TJ, Albert VR.
    Arthritis Rheum; 2003 Nov; 48(11):3253-65. PubMed ID: 14613291
    [Abstract] [Full Text] [Related]

  • 12. Placental transfer of a fully human IgG2 monoclonal antibody in the cynomolgus monkey, rat, and rabbit: a comparative assessment from during organogenesis to late gestation.
    Moffat GJ, Retter MW, Kwon G, Loomis M, Hock MB, Hall C, Bussiere J, Lewis EM, Chellman GJ.
    Birth Defects Res B Dev Reprod Toxicol; 2014 Apr; 101(2):178-88. PubMed ID: 24753333
    [Abstract] [Full Text] [Related]

  • 13. Chronic administration of belatacept, a T-cell costimulatory signal blocker, in cynomolgus monkeys.
    Haggerty HG, Proctor SJ.
    Toxicol Sci; 2012 May; 127(1):159-68. PubMed ID: 22331490
    [Abstract] [Full Text] [Related]

  • 14. The effects of prenatal ethanol in cynomolgus monkeys.
    Scott WJ, Fradkin R.
    Teratology; 1984 Feb; 29(1):49-56. PubMed ID: 6701806
    [Abstract] [Full Text] [Related]

  • 15. Effects of SA237, a humanized anti-interleukin-6 receptor monoclonal antibody, on pre- and postnatal development in cynomolgus monkey.
    Katagiri R, Ishihara-Hattori K, Frings W, Amano J, Fuchs A, Chiba S.
    Birth Defects Res; 2017 Jul 03; 109(11):843-856. PubMed ID: 28504465
    [Abstract] [Full Text] [Related]

  • 16. Effects of ICOS+ T cell depletion via afucosylated monoclonal antibody MEDI-570 on pregnant cynomolgus monkeys and the developing offspring.
    Nicholson SM, Carlesso G, Cheng LI, Cook H, DaCosta K, Leininger J, McKeever K, Scott SW, Taylor D, Streicher K, Eck S, Reed M, Faggioni R, Herbst R, Dixit R, Ryan PC.
    Reprod Toxicol; 2017 Dec 03; 74():116-133. PubMed ID: 28916434
    [Abstract] [Full Text] [Related]

  • 17. Investigation of maternal and fetal exposure to an IgG2 monoclonal antibody following biweekly intravaginal administration to cynomolgus monkeys throughout pregnancy.
    Moffat GJ, Davies R, Kwon G, Retter MW, Chellman GJ, Kanapuram S, Moore M, Loomis M, Wang W, Pyrah IT.
    Reprod Toxicol; 2014 Sep 03; 48():132-7. PubMed ID: 24859271
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of bendectin embryotoxicity in nonhuman primates: II. Double-blind study in term cynomolgus monkeys.
    Hendrickx AG, Cukierski M, Prahalada S, Janos G, Booher S, Nyland T.
    Teratology; 1985 Oct 03; 32(2):191-4. PubMed ID: 4049276
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics/dynamics of 5c8, a monoclonal antibody to CD154 (CD40 ligand) suppression of an immune response in monkeys.
    Gobburu JV, Tenhoor C, Rogge MC, Frazier DE, Thomas D, Benjamin C, Hess DM, Jusko WJ.
    J Pharmacol Exp Ther; 1998 Aug 03; 286(2):925-30. PubMed ID: 9694951
    [Abstract] [Full Text] [Related]

  • 20. Effect of anti-CD20 monoclonal antibody, Rituxan, on cynomolgus monkey and human B cells in a whole blood matrix.
    Vugmeyster Y, Howell K, Bakshl A, Flores C, Canova-Davis E.
    Cytometry A; 2003 Apr 03; 52(2):101-9. PubMed ID: 12655653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.